Biden dex bill expected
This article was originally published in The Tan Sheet
Executive Summary
A bill from Sen. Joe Biden, D-Del., that would place an age restriction of 18 on OTC sales of dextromethorphan is likely to be introduced before the August recess. The bill will not include language establishing pre-emption over potential state bills with greater restrictions, according to staffers, but will include funding for abuse prevention education efforts. Biden has worked with input from manufacturers and retailers (1"The Tan Sheet" March 12, 2007, p. 3). The bill will also address abuse of bulk DXM...
You may also be interested in...
Will Oklahoma Dextromethorphan Age Restriction Bill Lead The Way?
Increasing momentum in states for age restrictions on sales of dextromethorphan-containing cough/cold products could drive retail industry support for a federal bill mandating a uniform, nationwide age restriction
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.